October 23, 2023 |
PASS Issues Updated Mgen Testing Policy and Guidance |
PASS has announced that they will be updating its testing policy and guidance on Mycoplasma genitalium (“Mgen”) after further consultation with industry stakeholders and medical experts. The nonprofit organization explained that Mgen is a relatively new infection, and that their recommendations are subject to change as they receive new data. They further stated that they will keep the community informed as they learn more about the prevalence of and risks associated with Mgen. With that in mind, starting November 13th, PASS will implement the following changes: PASS continues to advise against requiring Mgen testing as part of regular 14-day work clearance expressing that there is no medical reason to test for Mgen more frequently than every 30 days, except in the following instances: Identifying and treating Mgen is vital for the safety of our community. PASS said that taking medication exactly as prescribed will help ensure the fastest clearance of the infection and ability to return to work and will help prevent drug resistance. If you have tested positive for Mgen, PASS also asks that you participate in their anonymous Mgen Contact Tracing Program, which identifies and notifies individuals who may have been exposed to Mgen in order to prevent further infections. Filling out this form is entirely anonymous and voluntary. Anyone with questions about the process or protocol can contact PASS at info@passcertified.org. PASS is committed to providing those who work in our industry with the most up to date information and guidance on STI prevention and other issues of health and well-being. Mgen testing is currently available at all PASS Certified testing partners. For more information about PASS head to their website at passcertified.org and follow them on X @PASScertified. |